PHI
PLDT Inc.
PHI offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
TMUS
T-Mobile US, Inc.
TMUS has the edge over PHI overall, supported by stronger valuation and stronger modeled upside.
PHI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Under pressure |
PHI's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is under pressure.
TMUS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
TMUS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
PHI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 7.8x | $16.13 | — |
| Cheap | 8.6x | $17.63 | +9.3% |
| Fair | 11x | $22.25 | +38% |
| Expensive | 22x | $46.34 | +187% |
Historical ranges are pointers, not guarantees.
PHI has the edge over TMUS in the historical PE scenario, which offers more potential upside but is not a forecast.
TMUS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $171 | — |
| Current | 16x | $171 | — |
| Cheap | 21x | $218 | +27% |
| Fair | 26x | $274 | +60% |
| Expensive | 56x | $581 | +240% |
Historical ranges are pointers, not guarantees.
TMUS's PE is in its cheap range at 16x. If earnings grow as analysts expect, today's price would be 13x next year's earnings.
PHI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect PHI's earnings and profitability to decline, with its revenue holding steady.
TMUS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
TMUS has the edge over PHI on the outlook, with more favorable earnings and revenue expectations.
PHI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $2.06 | -12% |
| Q1 2026 | $2.17 | -5.2% |
| Q4 2025 | $2.18 | -7.2% |
| Q3 2025 | $2.13 | +9.2% |
| Q2 2025 | $2.33 | +21% |
| Q1 2025 | $2.29 | +15% |
| Q4 2024 | $2.35 | +21% |
| Q3 2024 | $1.95 | +144% |
PHI has the edge over TMUS on earnings, with stronger typical year-over-year growth.
TMUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.49 | +30% |
| Q3 2026 | $10.37 | -0.2% |
| Q2 2026 | $9.56 | -9.7% |
| Q1 2026 | $9.41 | -8.1% |
| Q4 2025 | $9.72 | +0.6% |
| Q3 2025 | $10.39 | +18% |
| Q2 2025 | $10.59 | +33% |
| Q1 2025 | $10.24 | +39% |
| Q4 2024 | $9.66 | +39% |
TMUS earned $10.37 per share over the past year, about the same as the year before.
PHI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $873.8M | +2.2% |
| Q1 2026 | $889.9M | +2.2% |
| Q4 2025 | $864.8M | -1.7% |
| Q3 2025 | $845.7M | +0.7% |
| Q2 2025 | $855M | +1.8% |
| Q1 2025 | $870.4M | +1.9% |
| Q4 2024 | $880.1M | +2.4% |
| Q3 2024 | $840.2M | +2% |
PHI's revenue grew through 2022 and has held roughly level since: $874M last quarter, up 2.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 52% | +25 points |
| Q1 2026 | 50% | +22 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 52% | +46 points |
| Q2 2025 | 27% | +3.8 points |
| Q1 2025 | 28% | -0.6 points |
| Q4 2024 | 18% | -25 points |
| Q3 2024 | 5.8% | -46 points |
PHI has the edge over TMUS on profitability, with a higher operating margin.
TMUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.6B | +7.4% |
| Q2 2026 | $22.8B | +7.9% |
| Q1 2026 | $23.1B | +11% |
| Q4 2025 | $24.3B | +11% |
| Q3 2025 | $22B | +8.9% |
| Q2 2025 | $21.1B | +6.9% |
| Q1 2025 | $20.9B | +6.6% |
| Q4 2024 | $21.9B | +6.8% |
TMUS has the edge over PHI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +3.4 points |
| Q2 2026 | 24% | -0.6 points |
| Q1 2026 | 19% | -3.5 points |
| Q4 2025 | 15% | -5.6 points |
| Q3 2025 | 21% | -3.2 points |
| Q2 2025 | 25% | +1.3 points |
| Q1 2025 | 23% | +2.6 points |
| Q4 2024 | 21% | +4 points |
TMUS's operating margin was 24% last quarter, up 3.4 points from the same quarter a year ago.
PHI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $183.9M | +176% |
| Q1 2026 | $115.6M | -13% |
| Q4 2025 | $134.2M | +$228.6M |
| Q3 2025 | $173.9M | +88% |
| Q2 2025 | $66.5M | -51% |
| Q1 2025 | $132.3M | +68% |
| Q4 2024 | -$94.4M | -172% |
| Q3 2024 | $92.4M | -54% |
PHI generated $608M in free cash flow over the past year, about three times what it generated the year before.
TMUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +5.3% |
| Q2 2026 | $4.8B | +4.4% |
| Q1 2026 | $4.6B | +4.6% |
| Q4 2025 | $4.2B | +25% |
| Q3 2025 | $4.8B | +15% |
| Q2 2025 | $4.6B | +32% |
| Q1 2025 | $4.4B | +79% |
| Q4 2024 | $3.3B | +2% |
TMUS has the edge over PHI on cash flow, with more consistent year-over-year improvement.
PHI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -428K shares |
| 1 year | -0.2% | -442K shares |
| 3 years | 0% | -5K shares |
| 5 years | -0.2% | -520K shares |
| Available history | -0.5% | -1M shares |
PHI has 216M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
PHI hasn't bought back shares in the past year.
TMUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -10.8M shares |
| 1 year | -4.9% | -55M shares |
| 3 years | -8.8% | -103M shares |
| 5 years | -15% | -182M shares |
| Available history | +24% | +207M shares |
TMUS has the edge over PHI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.4B |
| Q2 2026 | $2.3B |
| Q1 2026 | $4.8B |
| Q4 2025 | $2.4B |
| Q3 2025 | $2.5B |
| Q2 2025 | $2.6B |
| Q1 2025 | $2.5B |
| Q4 2024 | $4.7B |
TMUS spent $12B buying back its own shares over the past year, down 1.7% from the year before.
PHI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.2x | Elevated |
| Q4 2025 | 3.7x | Elevated |
| Q3 2025 | 3.1x | Elevated |
| Q2 2025 | 3.0x | Moderate |
| Q1 2025 | 3.0x | Moderate |
| Q4 2024 | 3.1x | Elevated |
| Q3 2024 | 3.4x | Elevated |
PHI's net debt is about 3.2 years of its operating earnings (EBITDA), up from 3.0 years a year ago.
TMUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 2.4x | Moderate |
TMUS has the edge over PHI on leverage, with a lower net debt burden relative to earnings.
PHI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.4 | Neutral |
| Stochastic | 24.6 | Neutral |
PHI's weekly RSI is 36 (neutral) and its Stochastic is 25 (neutral).
TMUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 42.1 | Neutral |
TMUS's weekly RSI is 48 (neutral) and its Stochastic is 42 (neutral).
PHI PE vs Communication Services Sector
| Metric | PHI | Sector median | Relative |
|---|---|---|---|
| PE | 7.8x | 16x | 53% below |
| PE % | 5 | 26 | 21 pts below |
PHI has the edge over TMUS on valuation relative to its sector.
TMUS PE vs Communication Services Sector
| Metric | TMUS | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 16x | Same PE |
| PE % | 1 | 26 | 25 pts below |
TMUS is trading at 16x earnings, in line with the Communication Services sector's median of 16x.
PHI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.0 | 10% below |
| 20 week MA | $18.6 | 13% below |
| 50 week MA | $20.0 | 20% below |
| 100 week MA | $21.0 | 23% below |
| 200 week MA | $22.4 | 28% below |
PHI is in a downtrend: it's below all five of its weekly moving averages, and 28% below its 200-week average.
TMUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $159.1 | 7.5% above |
| 20 week MA | $172.0 | 0.5% below |
| 50 week MA | $187.8 | 8.9% below |
| 100 week MA | $212.9 | 20% below |
| 200 week MA | $188.7 | 9.4% below |
TMUS has the edge over PHI on trend strength, trading above more of its moving averages.
PHI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.8 | $28.0 | +41% |
| 2021 | $28.0 | $37.0 | +32% |
| 2022 | $37.0 | $22.7 | -39% |
| 2023 | $22.7 | $23.4 | +3.4% |
| 2024 | $23.4 | $22.1 | -5.8% |
| 2025 | $22.1 | $21.7 | -1.9% |
| 2026 YTD | $21.7 | $16.1 | -26% |
PHI has finished lower in three of the last six years. It's down 26% so far in 2026.
TMUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $77.2 | $132.9 | +72% |
| 2021 | $132.9 | $119.9 | -9.8% |
| 2022 | $119.9 | $140.0 | +17% |
| 2023 | $140.0 | $160.3 | +15% |
| 2024 | $160.3 | $223.0 | +39% |
| 2025 | $223.0 | $201.0 | -9.9% |
| 2026 YTD | $201.0 | $171.0 | -15% |
TMUS has the edge over PHI on returns for 2026, with the stronger performance.